Ifg Advisory, LLC Viatris Inc Transaction History

Ifg Advisory, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Jan 31, 2023	SELL	$8.72 - $11.56 $24,607 - $32,622	-2,822 Reduced 21.59%	10,249 $114,000
Q3 2022 Oct 28, 2022	BUY	$8.48 - $11.13 $15,068 - $19,778	1,777 Added 15.73%	13,071 $111,000
Q2 2022 Aug 04, 2022	SELL	$9.95 - $12.27 $398 - $490	-40 Reduced 0.35%	11,294 $118,000
Q1 2022 May 04, 2022	BUY	$9.81 - $15.4 $8,829 - $13,860	900 Added 8.63%	11,334 $123,000
Q4 2021 Feb 14, 2022	BUY	$12.09 - $14.68 $126,147 - $153,171	10,434 New	10,434 $141,000

1,102

933M

2.71M

2.4M

Ticker VTRS
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 1,212,669,952
Market Cap $15.2B
Description
Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...

Get notified when there are updates to the investment portfolio of Ifg Advisory, LLC, based on Form 13F filings with the SEC.

Stay updated on Ifg Advisory, LLC with notifications on news.